Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wedbush Maintains Outperform on Wingstop, Raises Price Target to $200

Wedbush Maintains Outperform on Wingstop, Raises Price Target to $200

Wedbush analyst Nick Setyan maintains Wingstop (NASDAQ:WING) with a Outperform and raises the price target from $177 to $200.

byBenzinga Newsdesk

February 23, 2023

1 minute read

Wedbush analyst Nick Setyan maintains Wingstop (NASDAQ:WING) with a Outperform and raises the price target from $177 to $200.

Citigroup Maintains Buy on Amazon.com, Lowers Price Target to $180

By Benzinga Newsdesk

July 14, 10:46 AM

Citigroup analyst Ronald Josey maintains Amazon.com (NASDAQ:AMZN) with a Buy and lowers the price target from $205 to $180.

AMZN

Academy Sports And Outdoors’ Q2 Bottom-Line Beats Street View; Reaffirms FY22 Top-Line Guidance

By Shivani Kumaresan

September 7, 9:34 AM

Academy Sports And Outdoors Inc (NASDAQ:ASO) reported a second-quarter FY22 sales decline of 5.8% year-on-year to $1.69 billion, missing the consensus…

ASO

Sarepta Therapeutics’ Next-Gen Duchenne Muscular Therapy Shows Efficacy At Less Frequent Dosing

By Vandana Singh

January 29, 12:48 PM

Sarepta Therapeutics unveils results from MOMENTUM study's Phase 2 trial for SRP-5051, a next-gen PPMO treatment targeting Duchenne muscular dystrophy.

SRPT